Crosstalk between Thyroid Hormone Receptor and Liver X Receptor in the Regulation of Selective Alzheimer's Disease Indicator-1 Gene Expression

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Ishida, Emi ^a   Hashimoto, Koshi ^a   Okada, Shuichi ^a   Satoh, Tetsurou ^a   Yamada, Masanobu ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; LIOTHYRONINE; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; LIVER X RECEPTOR ALPHA; SELADIN 1; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROXINE; TO 901217; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FOREBRAIN; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HORMONE RESPONSIVE ELEMENT; HYPOTHYROIDISM; IN VIVO STUDY; MALE; MOLECULAR INTERACTION; MOUSE; MUTANT; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SELADIN 1 GENE; UPREGULATION;

ALZHEIMER DISEASE; ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; MALE; MICE; MICE, INBRED C57BL; ORPHAN NUCLEAR RECEPTORS; PLASMIDS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR CROSS-TALK; RECEPTORS, THYROID HORMONE;

MUS;

EID: 84872867966     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054901     Document Type: Article

References (64)

1. Blennow K, de Leon MJ, Zetterberg H, (2006) Alzheimer's disease. Lancet 368: 387-403.
2. Di Paolo G, Kim TW, (2011) Linking lipids to Alzheimer's disease: cholesterol and beyond. Nature reviews Neuroscience 12: 284-296.
3. Nunez J, Celi FS, Ng L, Forrest D, (2008) Multigenic control of thyroid hormone functions in the nervous system. Molecular and cellular endocrinology 287: 1-12.
4. Konig S, Moura Neto V, (2002) Thyroid hormone actions on neural cells. Cellular and molecular neurobiology 22: 517-544.
5. Hashimoto K, Mori M, (2011) Crosstalk of thyroid hormone receptor and liver X receptor in lipid metabolism and beyond. Endocrine journal 58: 921-930.
6. Flamant F, Samarut J, (2003) Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends in endocrinology and metabolism 14: 85-90.
7. Jones I, Srinivas M, Ng L, Forrest D, (2003) The thyroid hormone receptor beta gene: structure and functions in the brain and sensory systems. Thyroid 13: 1057-1068.
8. Forrest D, Sjoberg M, Vennstrom B, (1990) Contrasting developmental and tissue-specific expression of alpha and beta thyroid hormone receptor genes. The EMBO journal 9: 1519-1528.
9. Mellstrom B, Naranjo JR, Santos A, Gonzalez AM, Bernal J, (1991) Independent expression of the alpha and beta c-erbA genes in developing rat brain. Molecular endocrinology 5: 1339-1350.
10. Bradley DJ, Towle HC, Young WS III, (1992) Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. The Journal of neuroscience: the official journal of the Society for Neuroscience 12: 2288-2302.
11. Dugbartey AT, (1998) Neurocognitive aspects of hypothyroidism. Archives of internal medicine 158: 1413-1418.
12. Davis JD, Stern RA, Flashman LA, (2003) Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly. Current psychiatry reports 5: 384-390.
13. Hashimoto K, Curty FH, Borges PP, Lee CE, Abel ED, et al. (2001) An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proceedings of the National Academy of Sciences of the United States of America 98: 3998-4003.
14. Fu AL, Zhou CY, Chen X, (2010) Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease. Neuropharmacology 58: 722-729.
15. Alzoubi KH, Gerges NZ, Aleisa AM, Alkadhi KA, (2009) Levothyroxin restores hypothyroidism-induced impairment of hippocampus-dependent learning and memory: Behavioral, electrophysiological, and molecular studies. Hippocampus 19: 66-78.
16. Rivas M, Naranjo JR, (2007) Thyroid hormones, learning and memory. Genes, brain, and behavior 6Suppl 1: 40-44.
17. Breteler MM, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, et al. (1991) Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. International journal of epidemiology 20Suppl 2: S36-42.
18. Ganguli M, Burmeister LA, Seaberg EC, Belle S, DeKosky ST, (1996) Association between dementia and elevated TSH: a community-based study. Biological psychiatry 40: 714-725.
19. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, et al. (2000) Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clinical endocrinology 53: 733-737.
20. de Jong FJ, den Heijer T, Visser TJ, de Rijke YB, Drexhage HA, et al. (2006) Thyroid hormones, dementia, and atrophy of the medial temporal lobe. The Journal of clinical endocrinology and metabolism 91: 2569-2573.
21. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, et al. (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. The Journal of neuroscience: the official journal of the Society for Neuroscience 20: 7345-7352.
22. Crameri A, Biondi E, Kuehnle K, Lutjohann D, Thelen KM, et al. (2006) The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. The EMBO journal 25: 432-443.
23. Kuehnle K, Crameri A, Kalin RE, Luciani P, Benvenuti S, et al. (2008) Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Molecular and cellular biology 28: 539-550.
24. Waterham HR, Koster J, Romeijn GJ, Hennekam RC, Vreken P, et al. (2001) Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. American journal of human genetics 69: 685-694.
25. Martin M, Dotti CG, Ledesma MD, (2010) Brain cholesterol in normal and pathological aging. Biochimica et biophysica acta 1801: 934-944.
26. Cecchi C, Rosati F, Pensalfini A, Formigli L, Nosi D, et al. (2008) Seladin-1/DHCR24 protects neuroblastoma cells against Abeta toxicity by increasing membrane cholesterol content. Journal of cellular and molecular medicine 12: 1990-2002.
27. Benvenuti S, Luciani P, Cellai I, Deledda C, Baglioni S, et al. (2008) Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors. The Journal of endocrinology 197: 437-446.
28. Apfel R, Benbrook D, Lernhardt E, Ortiz MA, Salbert G, et al. (1994) A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Molecular and cellular biology 14: 7025-7035.
29. Stulnig TM, Steffensen KR, Gao H, Reimers M, Dahlman-Wright K, et al. (2002) Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Molecular pharmacology 62: 1299-1305.
30. Whitney KD, Watson MA, Collins JL, Benson WG, Stone TM, et al. (2002) Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Molecular endocrinology 16: 1378-1385.
31. Koldamova RP, Lefterov IM, Staufenbiel M, Wolfe D, Huang S, et al. (2005) The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. The Journal of biological chemistry 280: 4079-4088.
32. Riddell DR, Zhou H, Comery TA, Kouranova E, Lo CF, et al. (2007) The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Molecular and cellular neurosciences 34: 621-628.
33. Burns MP, Vardanian L, Pajoohesh-Ganji A, Wang L, Cooper M, et al. (2006) The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo. Journal of neurochemistry 98: 792-800.
34. Wang Y, Rogers PM, Stayrook KR, Su C, Varga G, et al. (2008) The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene. Molecular pharmacology 74: 1716-1721.
35. Enmark E, Gustafsson JA, (2001) Comparing nuclear receptors in worms, flies and humans. Trends in pharmacological sciences 22: 611-615.
36. Berkenstam A, Farnegardh M, Gustafsson JA, (2004) Convergence of lipid homeostasis through liver X and thyroid hormone receptors. Mechanisms of ageing and development 125: 707-717.
37. Hashimoto K, Yamada M, Matsumoto S, Monden T, Satoh T, et al. (2006) Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone. Endocrinology 147: 4292-4302.
38. Hashimoto K, Ishida E, Matsumoto S, Okada S, Yamada M, et al. (2009) Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone. Endocrinology 150: 3417-3424.
39. Zhang Y, Yin L, Hillgartner FB, (2001) Thyroid hormone stimulates acetyl-coA carboxylase-alpha transcription in hepatocytes by modulating the composition of nuclear receptor complexes bound to a thyroid hormone response element. The Journal of biological chemistry 276: 974-983.
40. Gullberg H, Rudling M, Forrest D, Angelin B, Vennstrom B, (2000) Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Molecular endocrinology 14: 1739-1749.
41. Hashimoto K, Cohen RN, Yamada M, Markan KR, Monden T, et al. (2006) Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. The Journal of biological chemistry 281: 295-302.
42. Huuskonen J, Vishnu M, Pullinger CR, Fielding PE, Fielding CJ, (2004) Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor. Biochemistry 43: 1626-1632.
43. Hashimoto K, Matsumoto S, Yamada M, Satoh T, Mori M, (2007) Liver X receptor-alpha gene expression is positively regulated by thyroid hormone. Endocrinology 148: 4667-4675.
44. Hashimoto K, Yamada M, Monden T, Satoh T, Wondisford FE, et al. (2005) Thyrotropin-releasing hormone (TRH) specific interaction between amino terminus of P-Lim and CREB binding protein (CBP). Molecular and cellular endocrinology 229: 11-20.
45. Satoh T, Yamada M, Iwasaki T, Mori M, (1996) Negative regulation of the gene for the preprothyrotropin-releasing hormone from the mouse by thyroid hormone requires additional factors in conjunction with thyroid hormone receptors. The Journal of biological chemistry 271: 27919-27926.
46. Moser BK, Stevens GR, Watts CL, (1989) The 2-Sample T-Test Versus Satterthwaite Approximate F-Test. Communications in Statistics-Theory and Methods 18: 3963-3975.
47. Ruxton GD, (2006) The unequal variance t-test is an underused alternative to Student's t-test and the Mann-Whitney U test. Behavioral Ecology 17: 688-690.
48. Tan XJ, Fan XT, Kim HJ, Butler R, Webb P, et al. (2010) Liver X receptor beta and thyroid hormone receptor alpha in brain cortical layering. Proceedings of the National Academy of Sciences of the United States of America 107: 12305-12310.
49. Shibusawa N, Hollenberg AN, Wondisford FE, (2003) Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. The Journal of biological chemistry 278: 732-738.
50. Usala SJ, Menke JB, Watson TL, Wondisford FE, Weintraub BD, et al. (1991) A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor. Molecular endocrinology 5: 327-335.
51. Safer JD, Langlois MF, Cohen R, Monden T, John-Hope D, et al. (1997) Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone. Molecular endocrinology 11: 16-26.
52. Flynn TR, Hollenberg AN, Cohen O, Menke JB, Usala SJ, et al. (1994) A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. The Journal of biological chemistry 269: 32713-32716.
53. Collingwood TN, Rajanayagam O, Adams M, Wagner R, Cavailles V, et al. (1997) A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proceedings of the National Academy of Sciences of the United States of America 94: 248-253.
54. Morvan-Dubois G, Demeneix BA, Sachs LM, (2008) Xenopus laevis as a model for studying thyroid hormone signalling: from development to metamorphosis. Molecular and cellular endocrinology 293: 71-79.
55. Behl C, (2002) Estrogen can protect neurons: modes of action. The Journal of steroid biochemistry and molecular biology 83: 195-197.
56. Maggi A, Ciana P, Belcredito S, Vegeto E, (2004) Estrogens in the nervous system: mechanisms and nonreproductive functions. Annual review of physiology 66: 291-313.
57. Benvenuti S, Luciani P, Vannelli GB, Gelmini S, Franceschi E, et al. (2005) Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures. The Journal of clinical endocrinology and metabolism 90: 1775-1782.
58. Luciani P, Deledda C, Rosati F, Benvenuti S, Cellai I, et al. (2008) Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology 149: 4256-4266.
59. Liu Y, Xia X, Fondell JD, Yen PM, (2006) Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Molecular endocrinology 20: 483-490.
60. Chen JD, Evans RM, (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457.
61. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404.
62. Astapova I, Lee LJ, Morales C, Tauber S, Bilban M, et al. (2008) The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proceedings of the National Academy of Sciences of the United States of America 105: 19544-19549.
63. Fatourechi V, (2009) Subclinical hypothyroidism: an update for primary care physicians. Mayo Clinic proceedings Mayo Clinic 84: 65-71.
64. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, et al. (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA: the journal of the American Medical Association 291: 228-238.